Survival benefit of tamoxifen and aromatase inhibitor in male and female breast cancer

Overview of attention for article published in Journal of Cancer Research and Clinical Oncology, November 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (86th percentile)
High Attention Score compared to outputs of the same age and source (87th percentile)

Mentioned by

news: 1 news outlet

twitter: 10 X users

Citations

dimensions_citation: 30 Dimensions

Readers on

mendeley: 52 Mendeley

Summary News X Dimensions citations

So far, Altmetric has seen 1 news story.

Thrombosis a Risk With Tamoxifen in Male Breast Cancer

MedPage Today, 06 Feb 2019

Men with hormone receptor-positive (HR+) breast cancer treated with tamoxifen had more than a two-fold increased risk of…